Deutsche Bank
http://www.db.com/
Deutsche Bank is a leading global investment bank with a strong and profitable private clients franchise.
The company operates through three divisions: Corporate and Investment Bank (CIB), Private Clients and Asset Management (PCAM) and Corporate Investments (CI) . The CIB division engages in the origination, sale, financing, structuring, and trading of fixed income, equity, equity-linked, convertible bond, foreign exchange, and commodities products. The PCAM segment provides portfolio/fund management products, including active fund management, passive/quantitative fund management, alternative investments, and discretionary portfolio management solutions in Germany and other continental European countries.-
Notable Analyst Rating Changes 08/16: DYN, CHK, GNW, VMW Upgraded; COCO, DEG, CPLA, ESI Downgraded
-
Deutsche Bank Starts Amgen (AMGN) at Hold
-
Notable Analyst Rating Changes 04/22: SBUX, CMG, WFC, HBAN Upgraded; AMGN, TWX, HRL, PZZA Downgraded
-
David Moenning's Daily State of the Markets: Subtle, Yet Effective
-
Notable Analyst Rating Changes 8/11: FLR, SATS, DEO, QLGC, BEXP Upgraded; YUM, MBI, S Downgraded
-
David Moenning's Daily State of the Markets: 5/20
-
David Moenning's Daily State of the Markets: 3/27
-
Notable Analyst Rating Changes 3/27: AMGN, COP, JCP, UPS, CAG, CPWR Upgraded; FSLR, PBR, UTIW, STP, BHP Downgraded
-
David Moenning's Daily State of the Markets: 3/6
-
David Moenning's Daily State of the Markets: 10/23
-
David Moenning’s Daily State of the Markets: 07/29
-
Pre-Open Movers 7/29: U.S. Steel (X) Up on Strong Results; Zoran (ZRAN) Lower on Results/Guidance
-
David Moenning’s Daily State of the Markets: 7/28
-
Deutsche Bank Raises Their Price Target on Amgen (AMGN) to $73
-
Deutsche Bank Comments on Recent Strength in Amgen (AMGN), Cites Positive Buy-Side Meetings
-
Deutsche Bank Starts Amgen (AMGN) At Buy, Citing Appealing Risk/Reward
-
Deutsche Bank Starts Coverage on Large Biotechs; DNA, GILD & AMGN Rated Buys, BIIB & GENZ Rated Holds
-
David Moenning's Daily State of the Markets: 4/25
-
David Moenning's Daily State of the Markets: 1/25
